| Document |
Document Title |
|
WO/2024/085395A1 |
The present invention provides a method for preparing a hydroxyalkanoic acid and lactic acid, comprising the steps of: hydrolyzing a hydroxyalkanoate-lactide copolymer in the presence of an alkali metal salt, thereby preparing a hydroxya...
|
|
WO/2024/075535A1 |
In the present invention, there is employed a resist composition having, as a base resin, a polymer compound that has constituent units derived from a compound expressed by general formula (a0−m). In the formula, W is a polymerizable-g...
|
|
WO/2024/067626A1 |
A composite, comprising: 3-hydroxybutyric acid; and one or more of potassium 3-hydroxybutyrate, or calcium 3-hydroxybutyrate, or magnesium 3-hydroxybutyrate. A composite, wherein the anion comprises 3-hydroxyvaleric acid, and the cation ...
|
|
WO/2024/071125A1 |
A resist composition comprises: a resin component (A1), the solubility of which in a developer solution is changed by the action of acid; and a compound (D0) represented by general formula (d0). In the formula: Ar is an aromatic ring; Xd...
|
|
WO/2024/067085A1 |
The present invention relates to a citrate salt of a compound of formula (I). The present invention also relates to a crystal form A, a crystal form B, a crystal form C, and a crystal form D of the citrate salt of the compound of formula...
|
|
WO/2024/063611A2 |
The present invention relates to a hydroxy fatty acid and a hydroxy fatty acid derivative derived from long-chain fatty acids and functioning as agonists for fatty acid receptors such as GPR40 and GPR120. The hydroxy fatty acid and the h...
|
|
WO/2024/061362A1 |
The present invention provides a compound for preventing and treating vasodilator diseases, a preparation method therefor, and use thereof. Specifically, the present invention provides a compound of formula I and use thereof in treating ...
|
|
WO/2024/060737A1 |
Provided is a preparation process for the catalytic synthesis of 2,4-dichlorophenoxyacetic acid. Water is used as a solvent. Chloroacetic acid, sodium hydroxide or sodium carbonate, and 2,4-dichlorophenol are used as initial starting mat...
|
|
WO/2024/058216A1 |
Provided is a metal extraction agent for extracting metal ions present in an aqueous phase into an oil phase, wherein nitrogen atoms positioned at both ends of a molecular chain constituting the metal extraction agent do not constitute a...
|
|
WO/2024/059664A2 |
This invention relates to Compound 1 (APX3330) salts and esters. The invention also provides compositions comprising a Compound 1 salt or ester. The invention also provides compounds of formula (I) and formula (II) and pharmaceutically a...
|
|
WO/2024/053091A1 |
[Problem] The purpose of the present invention is to develop a low-cost and higher aspect ratio material that is available as a substitute for conventional high aspect ratio magnesium hydroxide which requires a large amount of a monocarb...
|
|
WO/2024/041182A1 |
The present application provides a ligand compound. The structure of the ligand compound is X-Y-L-(Z)n, wherein X is HOOC-, NH2-, HOOOP-, HSS-, or HS-; Y is at least one of a single bond, an aliphatic organic group, an aromatic organic g...
|
|
WO/2024/040182A1 |
Disclosed herein is the use of purified 2-S rimantadine or purified 2-R rimantadine or a pharmaceutically acceptable thereof to treat cancers and precancer lesions, including cancers and precancer lesions associated with papilloma virus ...
|
|
WO/2023/064363A9 |
The present disclosure relates to novel salts and salt forms of (2R)-2-(2-chlorophenyl)-2- (methylamino)cyclohexan-1-one (R-ketamine) and to processes for their preparation. The disclosure is also directed to pharmaceutical compositions ...
|
|
WO/2024/023821A1 |
The present invention relates to processes for the enantiomeric enrichment of lactic acid or salt thereof obtained from waste recycling.
|
|
WO/2024/025048A1 |
The present application relates to: a complex compound in which citrate and iron ion are coupled while forming a chemical formula; a food composition comprising same; and a preparation method therefor.
|
|
WO/2024/019698A1 |
Described herein is a process of producing α,β unsaturated acids and amides and their intermediates via a photocatalytic reaction in the presence of a photocatalyst, oxygen, and optionally a solvent. The photocatalyst contains a tungst...
|
|
WO/2024/015447A1 |
Pharmaceutically acceptable salts, esters and conjugates of psilocin and compositions and methods for their production and use in treating diseases or conditions treatable with psilocin or psilocybin are provided.
|
|
WO/2024/000002A1 |
The process relates to the preparation of levulinic acid from fructose by acid hydrolysis with hydrochloric acid as a catalyst, wherein fructose syrup (1) is mixed (34) with diluted hydrochloric acid and hydrolyzed in a reactor (5), pref...
|
|
WO/2024/003032A1 |
The invention relates to a method for obtaining an aminobenzoic acid or an aliphatic saturated C4- 6-dicarboxylic acid from an aqueous solution, comprising: A) producing the organic acid, wherein a) the organic acid is crystallised from ...
|
|
WO/2024/006568A1 |
The present disclosure is directed to salt forms of ʟ-Ergothioneine and crystalline forms thereof, and processes for their preparation. Also provided is a crystalline form of ʟ‑Ergothioneine (Form C) and a crystalline form of DL-Ergo...
|
|
WO/2024/000060A1 |
The present invention provides novel salts of belumosudil (I) and crystalline forms thereof. Specific salts of belumosudil provided by the present invention include L-malate, acesulfamate, fumarate, maleate, isethionate, malonate, edisyl...
|
|
WO/2023/248260A1 |
This invention relates to recovery of the solid fraction, rich in dimethylolpropionic acid, from the mother liquors of synthesis of the same. Specifically, the invention is intended for a process for recovery, substantially quantitative ...
|
|
WO/2023/244587A1 |
Disclosed herein are improved synthetic routes for making (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)
-1 H-imidazo[4,5-c ]pyridin-2(3H)-one (tolebrutinbib). Also disclosed herein are novel compounds used in the synthesis...
|
|
WO/2023/241117A1 |
A synthesis method for an easily-soluble guanidinoacetic acid complex, comprising: first, adding guanidine hydrochloride into an alkaline solution A to generate free guanidine and obtain a solution B; then dropwise adding chloroacetic ac...
|
|
WO/2023/232426A1 |
The present invention relates to a method for separating levulinic acid from a composition comprising levulinic acid and humins, in which said composition is subjected to a step of thermal separation in the presence of a flux having a bo...
|
|
WO/2023/232427A1 |
The present invention relates to a method for synthesising levulinic acid by hydration of furfuryl alcohol at a temperature of between 25 and 140°C in the presence of a homogeneous acid catalyst and of a solvent based on ether and/or ac...
|
|
WO/2023/226619A1 |
Provided in the present invention is a purification method for an electronic-grade citric acid. The method comprises dissolving industrial-grade solid citric acid having a relatively high impurity content to formulate a dilute citric aci...
|
|
WO/2023/230299A1 |
Methods and compositions for suppressing corrosion of a corrodible metal surface that contacts a water stream in a water system, such a those used in industrial processes. The method comprises introducing into the water stream a treatmen...
|
|
WO/2023/225144A1 |
The invention provides piperidinyl-methyl-purine amine salts, crystalline forms, pharmaceutical compositions, their use in inhibiting NSD2, and their use in the treatment of a disease or condition, such as cancer.
|
|
WO/2023/224418A1 |
The present invention relates to a method for producing, from fatty alcohols, various monomers that are used in the production of synthetic resins.
|
|
WO/2023/220606A1 |
The present invention provides compositions comprising granules of calcium citrate malate, compositions comprising granules of dicalcium malate, compositions comprising granules of dimagnesium malate, methods for preparing these composit...
|
|
WO/2023/210833A1 |
The present invention relates to oligomeric binaphtyl compounds of the formula (I) that are suitable as monomers for preparing thermoplastic resins, such as polycarbonate resins, which have beneficial optical and mechanical properties an...
|
|
WO/2023/205908A1 |
The present application provides a synthetic process for production of lipoxin B4 and analogues thereof, which is modular and scalable, thus permitting synthesis of large quantities of LXB4 and analogues thereof, including radiolabeled a...
|
|
WO/2023/202052A1 |
The present application relates to a method for preparing 10-oxo-nonadecanedioic acid. Compared with the corresponding synthesis methods in the prior art, the method features a high conversion rate, minimized side reactions, simplified p...
|
|
WO/2023/199284A1 |
Process for producing levulinic acid from cellulose derived from a biomass selected from artichoke scraps, wheat straw, rice straw, tomato plant stem, tomato peel, and legume pods in general, or a mixture thereof, characterised in that s...
|
|
WO/2023/197522A1 |
The present invention relates to the technical field of isotope-labeled drug synthesis, and specifically disclosed is a method for synthesizing a carbon isotope-labeled pyruvic acid, which method has few synthetic reaction steps, a high ...
|
|
WO/2023/194382A1 |
Disclosed herein is a salt of formula (I): wherein q is + or –; p is 2+, +, – or 2–; g is 1 or 2; G is selected from R5-C≡C-CO2 –, R5- C≡C-C(=O)S–, R5-C≡C-CS2 –, R5-C≡C-SO2 –, R5-C≡C-S(=O)S–, R5-C≡C-SO3 –, R...
|
|
WO/2023/196900A1 |
Provided herein are solid forms comprising a compound of formula (I), or a stereoisomer, or a mixture of stereoisomers thereof, or a pharmaceutically acceptable salt thereof. Also provided herein are methods of synthesizing a compound of...
|
|
WO/2023/187833A1 |
The invention relates to a novel diisopropylammonium salt of bempedoic acid of formula II, its polymorphic form and process of preparation thereof and further its conversion to bempedoic acid. The novel diisopropylammonium salt of bemped...
|
|
WO/2023/191756A1 |
Unfortunately, as a result of our bad experiences with Covid-19 about social hygiene and the spread of diseases, we have once again understood the importance of disinfectants and started to be more meticulous about the cleanliness of the...
|
|
WO/2023/187421A1 |
The application relates to the besylate, phosphate, tartrate, fumarate and succinate salts of mesembrine, also known as 3a-(3,4- dimethoxyphenyl)-octahydro-1-methyl-6H-indol-6-one. Mesembrine has the chemical formula C17H23NO3. The appli...
|
|
WO/2023/190164A1 |
The present invention provides: a method for producing a very pure aryl ester-containing carboxylic acid, wherein oligomer production is suppressed and a low-productivity purification step, such as column chromatography, is not required;...
|
|
WO/2023/179771A1 |
Provided herein are salts and crystalline forms of Compound (I), and salts, solvates, and salt solvates thereof. Also provided herein are pharmaceutical compositions comprising the crystalline forms, and therapeutic uses of the crystalli...
|
|
WO/2023/173717A1 |
The present invention relates to a preparation method for an intermediate compound acting as a posaconazole synthetic drug, and an intermediate compound prepared thereby. The preparation method for a compound of formula (I) provided by t...
|
|
WO/2023/174905A1 |
A process for the production of glycolic acid comprising subjecting an aqueous oxalic acid solution to a hydrogenation reaction in the presence of hydrogen and a metal containing hydrogenation catalyst, wherein the process is a continuou...
|
|
WO/2023/173227A1 |
Disclosed are novel C4-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same, including C4-ether-substituted tryptamine derivative compounds, C4-carbonic ester- substituted ...
|
|
WO/2023/176687A1 |
The present invention addresses the problem of providing a novel dicarboxylic acid compound that has a further improved refractive index. The solution is to provide a biphenanthrene compound, represented by general formula (1), or an alk...
|
|
WO/2023/174409A1 |
The present invention relates to a salt form and a crystal form of a Vanin enzyme inhibitor represented by formula I, a method for preparing same, and use thereof. The salt form is a salt formed by the compound represented by formula I w...
|
|
WO/2023/173229A1 |
Disclosed are salts of C4-carboxylic acid-substituted and C4-carbonothioate-substituted tryptamine derivative compounds represented by chemical formula (I), wherein R4 is a carboxylic acid moiety or a derivative thereof, or a carbonothio...
|
